Compare AMCX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMCX | QSI |
|---|---|---|
| Founded | 1980 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.2M | 273.7M |
| IPO Year | 2011 | N/A |
| Metric | AMCX | QSI |
|---|---|---|
| Price | $7.59 | $1.00 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $7.00 | $1.50 |
| AVG Volume (30 Days) | 503.9K | ★ 4.0M |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 132.55 | N/A |
| EPS | ★ 1.66 | N/A |
| Revenue | ★ $2,311,801,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $159.68 |
| P/E Ratio | $4.53 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.41 | $0.89 |
| 52 Week High | $10.28 | $3.10 |
| Indicator | AMCX | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 45.35 |
| Support Level | $6.96 | $0.92 |
| Resistance Level | $8.23 | $1.33 |
| Average True Range (ATR) | 0.50 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 28.25 | 50.64 |
AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.